Last reviewed · How we verify
Dextrose 50
At a glance
| Generic name | Dextrose 50 |
|---|---|
| Also known as | Glucose 50% solution, D50 |
| Sponsor | Hadassah Medical Organization |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial (NA)
- To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants (NA)
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (PHASE2)
- Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes (NA)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- Effects of Dual-Source Carbohydrate Intake and Liver Glycogen Repletion After Overnight Fasting. (NA)
- Fasted Exercise Training in Type 1 Diabetes (FED-T1D) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dextrose 50 CI brief — competitive landscape report
- Dextrose 50 updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI